Orion and Glykos announce the extension of research collaboration and licensing agreement for the development of next-gen ADCs June 24, 2025
Marker Therapeutics and Cellipont Bioservices to Advance cGMP Manufacturing of MT-601 for Patients with Lymphoma June 24, 2025
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel ADC Targeting CDH6 June 24, 2025
Enterome raises $19M to fund clinical development of OncoMimics™ immunotherapy to treat Follicular Lymphoma June 24, 2025
MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies June 24, 2025
Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3 to RayzeBio, a BMS Company, for a potential value of up to $1.35B plus royalties June 17, 2025
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel CDH6-targeting ADC June 17, 2025
Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases June 17, 2025
Enterome raises $19 million to fund clinical development of OncoMimics™ immunotherapy to treat Follicular Lymphoma June 17, 2025
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology June 17, 2025
Debiopharm And Alkyon Therapeutics Announce Research Collaboration To Advance The Next Generation Of Radioligand Therapies June 17, 2025
AstraZeneca enters strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research June 17, 2025
Vividion Therapeutics and Bayer Partnership Aims to Further Strengthen Oncology Pipeline With Solid Tumor Inhibitor June 11, 2025
Medicovestor, Inc. and Sanyou Biopharmaceuticals to Develop First-in-Class Chemoimmunotherapy ADCs June 11, 2025
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US June 11, 2025
OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies June 11, 2025
Astellas Enters Exclusive License Agreement with Evopoint Biosciences for CLDN18.2-targeting ADC XNW27011 June 3, 2025
BioNTech and BMS to Co-Develop and Co-Commercialize BNT327 for Multiple Solid Tumor Types June 3, 2025
